Use of a low molecular weight heparin (enoxaparin) as an anticoagulant for cardiopulmonary bypass (CPB).

被引：0
|
作者：
Lutz, P [1 ]
Moody, C [1 ]
Levitsky, S [1 ]
机构：
[1] DEACONESS HOSP,BOSTON,MA
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3064 / 3064
页数：1
相关论文
共 50 条
  • [1] EVALUATION OF A LOW-MOLECULAR-WEIGHT HEPARIN AS AN ANTICOAGULANT IN A MODEL OF CARDIOPULMONARY BYPASS-SURGERY
    KOZA, MJ
    MESSMORE, HL
    WALLOCK, ME
    WALENGA, JM
    PIFARRE, R
    THROMBOSIS RESEARCH, 1993, 70 (01) : 67 - 76
  • [2] CARDIOPULMONARY BYPASS WITH A LOW-MOLECULAR-WEIGHT HEPARIN FRACTION (ENOXAPARIN) IN A PATIENT WITH A HISTORY OF HEPARIN-ASSOCIATED THROMBOCYTOPENIA
    ROBITAILLE, D
    LECLERC, JR
    LABERGE, R
    SAHAB, P
    ATKINSON, S
    CARTIER, R
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 103 (03): : 597 - 599
  • [3] CARDIOPULMONARY BYPASS WITH A LOW-MOLECULAR-WEIGHT HEPARIN FRACTION
    GOUAULTHEILMANN, M
    HUET, Y
    CONTANT, G
    PAYEN, D
    BLOCH, G
    RAPIN, M
    LANCET, 1983, 2 (8363): : 1374 - 1374
  • [4] ON THE RELATIONSHIP BETWEEN MOLECULAR MASS AND ANTICOAGULANT ACTIVITY IN A LOW-MOLECULAR-WEIGHT HEPARIN (ENOXAPARIN)
    BENDETOWICZ, AV
    PACAUD, E
    BEGUIN, S
    UZAN, A
    HEMKER, HC
    THROMBOSIS AND HAEMOSTASIS, 1992, 67 (05) : 556 - 562
  • [5] HEPARIN MONITORING DURING CARDIOPULMONARY BYPASS (CPB)
    SALEHSHENAQ, S
    SALEEM, A
    YAWN, D
    HARSBERGER, K
    DIEMUNSCH, P
    MOHINDRA, P
    ANESTHESIA AND ANALGESIA, 1984, 63 (02): : 271 - 271
  • [6] Advantages of low dose heparin and heparin bonded surfaces during cardiopulmonary bypass (CPB)
    Khuri, SF
    Healey, NA
    Hassanein, WH
    Birjiniuk, V
    Crittenden, MD
    Tyrrell, TA
    Treanor, PA
    Bauer, K
    Valeri, R
    CIRCULATION, 1998, 98 (17) : 526 - 526
  • [7] USE OF LOW-MOLECULAR-WEIGHT HEPARIN AS AN ANTICOAGULANT IN PREGNANCY
    KELBEL, C
    HAFNER, G
    SCHINZEL, H
    PRELLWITZ, W
    WEILEMANN, LS
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 119 (44) : 1497 - 1500
  • [8] A COMPARISON OF A LOW-MOLECULAR WEIGHT HEPARIN WITH UNFRACTIONATED HEPARIN IN A DOG CARDIOPULMONARY BYPASS MODEL
    MESSMORE, H
    KOZA, M
    WALLOCK, M
    BAKHOS, M
    WALENGA, JM
    PIFARRE, R
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 525 - 525
  • [9] LOW-MOLECULAR-WEIGHT HEPARIN IN A PATIENT WITH THROMBOCYTOPENIA INDUCED BY HEPARIN AND TREATED WITH A CARDIOPULMONARY BYPASS
    PARAMA, JA
    LLORENS, R
    DEBURUAGA, JS
    ROCHA, E
    MEDICINA CLINICA, 1994, 102 (16): : 637 - 638
  • [10] Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin
    Mousa, Shaker A.
    Linhardt, Robert
    Francis, John L.
    Amirkhosravi, Ali
    THROMBOSIS AND HAEMOSTASIS, 2006, 96 (06) : 816 - 821
12345